Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5427]
News [12612]
Articles [172]
Editorials [5]
Conferences [246]
elearning [17]
DNA methylation as a mediator of in utero exposures on the risk of childhood ALL
Jessica Timms - PhD student, Newcastle University, Newcastle, UK
DNA methylation as a mediator of in utero exposures on the risk of childhood ALL ( Jessica Timms - PhD student, Newcastle University, Newcastle, UK )
23 Sep 2016
The timeline of adjuvant and neoadjuvant therapy for melanoma
Dr Jean Jacques Grob - Hôpital de la Timone, Marseille, France
The timeline of adjuvant and neoadjuvant therapy for melanoma ( Dr Jean Jacques Grob - Hôpital de la Timone, Marseille, France )
23 Sep 2016
Targeted therapies in melanoma
Dr Dirk Schadendorf - University Hospital Essen, Essen, Germany
Targeted therapies in melanoma ( Dr Dirk Schadendorf - University Hospital Essen, Essen, Germany )
23 Sep 2016
Causes, symptoms, and prevention of skin cancer
Dr Veronique Del Marmol - Université Libre de Bruxelles, Brussels, Belgium
Causes, symptoms, and prevention of skin cancer ( Dr Veronique Del Marmol - Université Libre de Bruxelles, Brussels, Belgium )
23 Sep 2016
Treatment of cutaneous T cell lymphoma
Dr Madeleine Duvic - Anderson Cancer Center, Houston, USA
Treatment of cutaneous T cell lymphoma ( Dr Madeleine Duvic - Anderson Cancer Center, Houston, USA )
22 Sep 2016
Skin cancer lesions arising in uncommon regions
Dr Josep Malvehy - University Hospital Clinic of Barcelona, Barcelona, Spain
Skin cancer lesions arising in uncommon regions ( Dr Josep Malvehy - University Hospital Clinic of Barcelona, Barcelona, Spain )
22 Sep 2016
Developments in checkpoint immunotherapy
Dr James Larkin - The Royal Marsden NHS Foundation Trust, London, UK
Developments in checkpoint immunotherapy ( Dr James Larkin - The Royal Marsden NHS Foundation Trust, London, UK )
22 Sep 2016
Targetted medicine to reduce melanoma mutational burden
Prof Grant McArthur - The Royal Melbourne Hospital, Melbourne, Australia
Targetted medicine to reduce melanoma mutational burden ( Prof Grant McArthur - The Royal Melbourne Hospital, Melbourne, Australia )
22 Sep 2016
Checkpoint inhibitor therapy for treating melanoma
Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA
Checkpoint inhibitor therapy for treating melanoma ( Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA )
22 Sep 2016
Metabolomics: Reversing drug resistance
Dr Olivier Pardo - Imperial College London, London, UK
Metabolomics: Reversing drug resistance ( Dr Olivier Pardo - Imperial College London, London, UK )
14 Sep 2016
Tumour heterogeneity and the impact on patient care
Dr Nicholas McGranahan - The Francis Crick Institute, London, UK
Tumour heterogeneity and the impact on patient care ( Dr Nicholas McGranahan - The Francis Crick Institute, London, UK )
14 Sep 2016
Developing new models in SCLC
Prof Caroline Dive - Cancer Research UK Manchester Institute, Manchester, UK
Developing new models in SCLC ( Prof Caroline Dive - Cancer Research UK Manchester Institute, Manchester, UK )
14 Sep 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation